Skip to main content

BIOTECHS DEMAND PRECISION, SPEED, AND CONTROL

Dermatology Expertise Built for Precision and Progress

HiRO Dermatology IRO

Dermatology trials demand scientific precision, operational speed, and deep understanding of complex skin biology. Our teams bring together global experience, early-phase capability, and data-driven execution to guide programs with clarity and confidence.

Through our HiRO LINKAGE™ Approach, we connect clinical insight, advanced imaging, and real-time data into a unified framework—helping sponsors anticipate challenges, reduce variability, and make informed decisions earlier in development.

IRO for Dermatology
HiRO Dermatology IRO

Our dermatology experience spans early-phase exploration through proof-of-concept confirmation. It reflects the discipline, transparency, and consistency required to move complex dermatology programs forward without compromise.

Dermatology Indications

HiRO supports a broad range of dermatology indications across inflammatory, infectious, oncologic, aesthetic, and rare skin disorders, with experience in topical, systemic, and biologic therapies.

Inflammatory & Immune-Mediated Conditions

  • Atopic Dermatitis
  • Psoriasis
  • Urticaria

Hair & Scalp Disorders

  • Alopecia
  • Androgenetic Alopecia (AGA)

Infectious & Dermatologic Diseases

  • Staphylococcal Skin Infections
  • Antiviral & Antifungal Therapies

Skin Oncology

  • Basal Cell Carcinoma

Aesthetic & Cosmetic Dermatology

  • Glabellar Lines
  • Lateral Canthal Lines
  • Port-Wine Birthmark

Rare & Genetic Disorders

  • Epidermolysis Bullosa Simplex (EBS)

Dermatology Experience By The Numbers

Our dermatology experience combines operational discipline with specialized clinical execution—supporting early-phase and adaptive study designs across global regions. These numbers reflect more than scale, they represent precision, responsiveness, and control sponsors rely on when dermatology studies demand accuracy at every step.

6.7

Patients Enrolled

600

Dermatology Sites Globally

How We Accelerated Early-Phase Dermatology Execution

See how HiRO delivered rapid start-up and disciplined early-phase execution for a Phase I dermatology study, supporting a UK biotech seeking speed, regulatory clarity, and investor-critical milestones. This case highlights regionally informed planning, concurrent approvals, and operational precision under compressed timelines.

HiRO Oncology Study

Rapid Phase I Dermatology Start-Up

Download Study
40

Days from final protocol receipt to full regulatory approval.

4

Days from regulatory approval to first Site Initiation Visit (SIV).

DISCIPLINE MEETS ADAPTIVE EXECUTION

A Modern Approach
To Dermatology

Dermatology studies require speed without sacrificing rigor. With complex lesion assessments, imaging requirements, and evolving regulatory expectations, sponsors need a partner who brings structure to complexity and clarity to every decision.

HiRO combines global early-phase strength with regionally aligned execution to ensure every dermatology program benefits from unified standards and deeply connected teams. Through our Linkage™ Approach, studies progress with consistent communication, aligned expectations, and confidence grounded in data.

Regulatory Confidence,
End-to-End

We don’t just manage timelines—we help sponsors navigate the full regulatory journey with confidence. From early strategy through IND and dermatology-specific requirements, our teams bring deep expertise in global compliance, safety, and submission readiness.

Proactive Planning: Anticipating dermatology-specific risks before they impact timelines

Integrated Execution: Aligning clinical, regulatory, and operational strategy

Global Perspective: Supporting multi-regional development with consistent standards

Collaborative Partnership: Working side-by-side to ensure clarity and compliance

Our goal is simple: help you move from concept to clinic efficiently—without compromising safety, quality, or dermatologic precision.

Book A Meeting With
Our Dermatology Team

Schedule Today